nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefazolin—PON1—polycystic ovary syndrome	0.965	1	CbGaD
Cefazolin—SLC22A8—urine—polycystic ovary syndrome	0.00416	0.163	CbGeAlD
Cefazolin—PON1—endocrine gland—polycystic ovary syndrome	0.0038	0.149	CbGeAlD
Cefazolin—TPMT—adrenal cortex—polycystic ovary syndrome	0.00185	0.0724	CbGeAlD
Cefazolin—TPMT—endometrium—polycystic ovary syndrome	0.00165	0.0647	CbGeAlD
Cefazolin—TPMT—pituitary gland—polycystic ovary syndrome	0.00149	0.0585	CbGeAlD
Cefazolin—TPMT—adipose tissue—polycystic ovary syndrome	0.00149	0.0583	CbGeAlD
Cefazolin—TPMT—adrenal gland—polycystic ovary syndrome	0.00133	0.0523	CbGeAlD
Cefazolin—TPMT—female gonad—polycystic ovary syndrome	0.00124	0.0488	CbGeAlD
Cefazolin—TPMT—vagina—polycystic ovary syndrome	0.00124	0.0485	CbGeAlD
Cefazolin—SLC22A11—endocrine gland—polycystic ovary syndrome	0.00122	0.0479	CbGeAlD
Cefazolin—TPMT—endocrine gland—polycystic ovary syndrome	0.00116	0.0453	CbGeAlD
Cefazolin—ABCC4—uterus—polycystic ovary syndrome	0.000913	0.0358	CbGeAlD
Cefazolin—ABCC4—adipose tissue—polycystic ovary syndrome	0.000893	0.035	CbGeAlD
Cefazolin—ALB—adrenal gland—polycystic ovary syndrome	0.000827	0.0325	CbGeAlD
Cefazolin—ABCC4—adrenal gland—polycystic ovary syndrome	0.000801	0.0314	CbGeAlD
Cefazolin—ABCC4—female gonad—polycystic ovary syndrome	0.000747	0.0293	CbGeAlD
Cefazolin—ABCC4—ABC-family proteins mediated transport—ABCB6—polycystic ovary syndrome	0.000714	0.0719	CbGpPWpGaD
Cefazolin—ABCC4—endocrine gland—polycystic ovary syndrome	0.000695	0.0273	CbGeAlD
Cefazolin—ABCC4—Drug Induction of Bile Acid Pathway—SULT2A1—polycystic ovary syndrome	0.000429	0.0432	CbGpPWpGaD
Cefazolin—ABCC4—Ectoderm Differentiation—RHPN1—polycystic ovary syndrome	0.000378	0.0381	CbGpPWpGaD
Cefazolin—TPMT—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000323	0.0325	CbGpPWpGaD
Cefazolin—TPMT—Phase II conjugation—SULT2A1—polycystic ovary syndrome	0.000286	0.0288	CbGpPWpGaD
Cefazolin—ABCC4—Fluoropyrimidine Activity—RRM2—polycystic ovary syndrome	0.000245	0.0246	CbGpPWpGaD
Cefazolin—ABCC4—Ectoderm Differentiation—TOX3—polycystic ovary syndrome	0.000244	0.0245	CbGpPWpGaD
Cefazolin—ALB—Bile acid and bile salt metabolism—AKR1C2—polycystic ovary syndrome	0.000208	0.021	CbGpPWpGaD
Cefazolin—TPMT—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000179	0.0181	CbGpPWpGaD
Cefazolin—TPMT—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000167	0.0169	CbGpPWpGaD
Cefazolin—TPMT—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000165	0.0166	CbGpPWpGaD
Cefazolin—TPMT—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000148	0.0149	CbGpPWpGaD
Cefazolin—TPMT—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000146	0.0147	CbGpPWpGaD
Cefazolin—TPMT—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000138	0.0139	CbGpPWpGaD
Cefazolin—TPMT—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000138	0.0139	CbGpPWpGaD
Cefazolin—TPMT—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000136	0.0137	CbGpPWpGaD
Cefazolin—ABCC4—Fluoropyrimidine Activity—MTHFR—polycystic ovary syndrome	0.000124	0.0125	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—GP1BB—polycystic ovary syndrome	0.000119	0.012	CbGpPWpGaD
Cefazolin—ALB—Bile acid and bile salt metabolism—AKR1C1—polycystic ovary syndrome	0.000116	0.0117	CbGpPWpGaD
Cefazolin—TPMT—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000109	0.011	CbGpPWpGaD
Cefazolin—TPMT—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000108	0.0108	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000102	0.0103	CbGpPWpGaD
Cefazolin—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—polycystic ovary syndrome	0.000101	0.0102	CbGpPWpGaD
Cefazolin—ABCC4—Ectoderm Differentiation—DMD—polycystic ovary syndrome	9.97e-05	0.01	CbGpPWpGaD
Cefazolin—ALB—FOXA2 and FOXA3 transcription factor networks—IGFBP1—polycystic ovary syndrome	9.31e-05	0.00938	CbGpPWpGaD
Cefazolin—ALB—Bile acid and bile salt metabolism—AKR1C3—polycystic ovary syndrome	8.92e-05	0.00898	CbGpPWpGaD
Cefazolin—TPMT—Biological oxidations—CYP1A1—polycystic ovary syndrome	8.79e-05	0.00885	CbGpPWpGaD
Cefazolin—TPMT—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	8.67e-05	0.00873	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	7.78e-05	0.00783	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—NMNAT3—polycystic ovary syndrome	7.74e-05	0.00779	CbGpPWpGaD
Cefazolin—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—polycystic ovary syndrome	7.71e-05	0.00776	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	7.46e-05	0.00751	CbGpPWpGaD
Cefazolin—ALB—FOXA2 and FOXA3 transcription factor networks—TFRC—polycystic ovary syndrome	7.4e-05	0.00745	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	7.27e-05	0.00732	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—INSR—polycystic ovary syndrome	7.1e-05	0.00715	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—SUOX—polycystic ovary syndrome	7.07e-05	0.00712	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—LPCAT2—polycystic ovary syndrome	7.07e-05	0.00712	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—ISYNA1—polycystic ovary syndrome	6.58e-05	0.00662	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	6.57e-05	0.00662	CbGpPWpGaD
Cefazolin—TPMT—Biological oxidations—POMC—polycystic ovary syndrome	6.56e-05	0.0066	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	6.49e-05	0.00654	CbGpPWpGaD
Cefazolin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—polycystic ovary syndrome	6.43e-05	0.00648	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—GP1BB—polycystic ovary syndrome	6.14e-05	0.00618	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—PLAT—polycystic ovary syndrome	6.11e-05	0.00615	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—INSR—polycystic ovary syndrome	5.78e-05	0.00582	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—TEAD2—polycystic ovary syndrome	5.59e-05	0.00563	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—AKR1C2—polycystic ovary syndrome	5.59e-05	0.00563	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	5.54e-05	0.00558	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—GP1BB—polycystic ovary syndrome	5.39e-05	0.00543	CbGpPWpGaD
Cefazolin—ABCC4—NRF2 pathway—SLC2A4—polycystic ovary syndrome	5.33e-05	0.00536	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	5.32e-05	0.00535	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	5.01e-05	0.00505	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—PLAT—polycystic ovary syndrome	4.97e-05	0.00501	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	4.81e-05	0.00484	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PNPLA2—polycystic ovary syndrome	4.69e-05	0.00472	CbGpPWpGaD
Cefazolin—ABCC4—Platelet degranulation—IGF1—polycystic ovary syndrome	4.68e-05	0.00472	CbGpPWpGaD
Cefazolin—ALB—FOXA2 and FOXA3 transcription factor networks—NR3C1—polycystic ovary syndrome	4.65e-05	0.00469	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	4.63e-05	0.00466	CbGpPWpGaD
Cefazolin—SLC22A11—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	4.59e-05	0.00462	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—INSR—polycystic ovary syndrome	4.59e-05	0.00462	CbGpPWpGaD
Cefazolin—ABCC4—Response to elevated platelet cytosolic Ca2+—IGF1—polycystic ovary syndrome	4.46e-05	0.00449	CbGpPWpGaD
Cefazolin—ABCC4—Platelet degranulation—SERPINE1—polycystic ovary syndrome	4.45e-05	0.00448	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—SRD5A1—polycystic ovary syndrome	4.44e-05	0.00447	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—STAR—polycystic ovary syndrome	4.24e-05	0.00427	CbGpPWpGaD
Cefazolin—ABCC4—Response to elevated platelet cytosolic Ca2+—SERPINE1—polycystic ovary syndrome	4.24e-05	0.00427	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	4.18e-05	0.00421	CbGpPWpGaD
Cefazolin—ABCC4—NRF2 pathway—NRG1—polycystic ovary syndrome	4.18e-05	0.00421	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PDE3B—polycystic ovary syndrome	4.12e-05	0.00415	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—PLAT—polycystic ovary syndrome	3.95e-05	0.00398	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—MTHFR—polycystic ovary syndrome	3.95e-05	0.00398	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—HMMR—polycystic ovary syndrome	3.78e-05	0.0038	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—CRP—polycystic ovary syndrome	3.76e-05	0.00378	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—HSD3B1—polycystic ovary syndrome	3.6e-05	0.00363	CbGpPWpGaD
Cefazolin—ALB—FOXA2 and FOXA3 transcription factor networks—INS—polycystic ovary syndrome	3.54e-05	0.00356	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—RACGAP1—polycystic ovary syndrome	3.53e-05	0.00355	CbGpPWpGaD
Cefazolin—SLC22A8—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	3.5e-05	0.00353	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	3.38e-05	0.0034	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—LHB—polycystic ovary syndrome	3.29e-05	0.00331	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—MTHFR—polycystic ovary syndrome	3.21e-05	0.00324	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—HSD3B2—polycystic ovary syndrome	3.21e-05	0.00323	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—INS—polycystic ovary syndrome	3.14e-05	0.00316	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—AKR1C1—polycystic ovary syndrome	3.11e-05	0.00313	CbGpPWpGaD
Cefazolin—ABCC4—Platelet degranulation—VEGFA—polycystic ovary syndrome	3.06e-05	0.00308	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—CRP—polycystic ovary syndrome	3.06e-05	0.00308	CbGpPWpGaD
Cefazolin—SLC22A6—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	2.92e-05	0.00294	CbGpPWpGaD
Cefazolin—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—polycystic ovary syndrome	2.91e-05	0.00293	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	2.89e-05	0.00291	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—SERPINE1—polycystic ovary syndrome	2.89e-05	0.00291	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—SULT2A1—polycystic ovary syndrome	2.86e-05	0.00288	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—GP1BB—polycystic ovary syndrome	2.78e-05	0.0028	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—RRM2—polycystic ovary syndrome	2.77e-05	0.00279	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	2.74e-05	0.00276	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—YAP1—polycystic ovary syndrome	2.67e-05	0.00269	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—NAMPT—polycystic ovary syndrome	2.57e-05	0.00259	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—INS—polycystic ovary syndrome	2.56e-05	0.00257	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—MTHFR—polycystic ovary syndrome	2.55e-05	0.00257	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	2.55e-05	0.00257	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CYP11A1—polycystic ovary syndrome	2.54e-05	0.00255	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—CRP—polycystic ovary syndrome	2.43e-05	0.00245	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	2.41e-05	0.00242	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—AKR1C3—polycystic ovary syndrome	2.39e-05	0.00241	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CYP17A1—polycystic ovary syndrome	2.36e-05	0.00237	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—SERPINE1—polycystic ovary syndrome	2.35e-05	0.00236	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	2.33e-05	0.00235	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	2.29e-05	0.0023	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	2.29e-05	0.0023	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	2.18e-05	0.00219	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PLAT—polycystic ovary syndrome	2.15e-05	0.00217	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—IGF1—polycystic ovary syndrome	2.12e-05	0.00213	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	2.09e-05	0.00211	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—IGF1—polycystic ovary syndrome	2.08e-05	0.00209	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—AKT2—polycystic ovary syndrome	2.08e-05	0.00209	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—TH—polycystic ovary syndrome	2.04e-05	0.00205	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—INS—polycystic ovary syndrome	2.03e-05	0.00204	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—polycystic ovary syndrome	2.02e-05	0.00203	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—SERPINE1—polycystic ovary syndrome	2.01e-05	0.00203	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	2.01e-05	0.00202	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—SLC2A4—polycystic ovary syndrome	1.98e-05	0.002	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—SERPINE1—polycystic ovary syndrome	1.97e-05	0.00199	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	1.96e-05	0.00197	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	1.95e-05	0.00196	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—polycystic ovary syndrome	1.92e-05	0.00193	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	1.92e-05	0.00193	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CYP19A1—polycystic ovary syndrome	1.87e-05	0.00188	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—SERPINE1—polycystic ovary syndrome	1.87e-05	0.00188	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	1.87e-05	0.00188	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PDE3B—polycystic ovary syndrome	1.86e-05	0.00188	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	1.82e-05	0.00183	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	1.78e-05	0.00179	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	1.75e-05	0.00176	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	1.73e-05	0.00175	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	1.71e-05	0.00172	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—GNAS—polycystic ovary syndrome	1.67e-05	0.00168	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—GNAS—polycystic ovary syndrome	1.65e-05	0.00167	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	1.62e-05	0.00163	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—RACGAP1—polycystic ovary syndrome	1.6e-05	0.00161	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—NCOR1—polycystic ovary syndrome	1.59e-05	0.0016	CbGpPWpGaD
Cefazolin—ALB—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	1.52e-05	0.00153	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CYP1A1—polycystic ovary syndrome	1.5e-05	0.00151	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	1.49e-05	0.0015	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	1.48e-05	0.0015	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	1.47e-05	0.00148	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	1.43e-05	0.00144	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NMNAT3—polycystic ovary syndrome	1.41e-05	0.00142	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—MTHFR—polycystic ovary syndrome	1.4e-05	0.00141	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—VEGFA—polycystic ovary syndrome	1.38e-05	0.00139	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—IL6—polycystic ovary syndrome	1.37e-05	0.00138	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	1.36e-05	0.00137	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	1.34e-05	0.00135	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—polycystic ovary syndrome	1.32e-05	0.00133	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	1.31e-05	0.00132	CbGpPWpGaD
Cefazolin—ALB—Metabolism—LPCAT2—polycystic ovary syndrome	1.29e-05	0.0013	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SUOX—polycystic ovary syndrome	1.29e-05	0.0013	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	1.27e-05	0.00128	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	1.25e-05	0.00125	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ISYNA1—polycystic ovary syndrome	1.2e-05	0.00121	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	1.17e-05	0.00118	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PPARG—polycystic ovary syndrome	1.14e-05	0.00114	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—POMC—polycystic ovary syndrome	1.12e-05	0.00113	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—IL6—polycystic ovary syndrome	1.12e-05	0.00112	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—INS—polycystic ovary syndrome	1.12e-05	0.00112	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	1.09e-05	0.0011	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—IGF1—polycystic ovary syndrome	1.07e-05	0.00108	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—AKT2—polycystic ovary syndrome	1.07e-05	0.00108	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	1.04e-05	0.00104	CbGpPWpGaD
Cefazolin—ALB—Metabolism—AKR1C2—polycystic ovary syndrome	1.02e-05	0.00103	CbGpPWpGaD
Cefazolin—ALB—Metabolism—TEAD2—polycystic ovary syndrome	1.02e-05	0.00103	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—SERPINE1—polycystic ovary syndrome	1.02e-05	0.00102	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	9.8e-06	0.000986	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PLAT—polycystic ovary syndrome	9.75e-06	0.000982	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	9.64e-06	0.000971	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—IGF1—polycystic ovary syndrome	9.4e-06	0.000947	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—AKT2—polycystic ovary syndrome	9.4e-06	0.000946	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	9.08e-06	0.000914	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—SERPINE1—polycystic ovary syndrome	8.93e-06	0.000899	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	8.87e-06	0.000893	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PNPLA2—polycystic ovary syndrome	8.54e-06	0.00086	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	8.44e-06	0.00085	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SRD5A1—polycystic ovary syndrome	8.09e-06	0.000815	CbGpPWpGaD
Cefazolin—ALB—Metabolism—STAR—polycystic ovary syndrome	7.72e-06	0.000777	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	7.72e-06	0.000777	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	7.63e-06	0.000768	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—GNAS—polycystic ovary syndrome	7.48e-06	0.000753	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—VEGFA—polycystic ovary syndrome	7e-06	0.000704	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HMMR—polycystic ovary syndrome	6.88e-06	0.000693	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HSD3B1—polycystic ovary syndrome	6.57e-06	0.000661	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	6.49e-06	0.000653	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	6.48e-06	0.000652	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	6.15e-06	0.000619	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	6.14e-06	0.000618	CbGpPWpGaD
Cefazolin—ALB—Metabolism—LHB—polycystic ovary syndrome	5.99e-06	0.000603	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HSD3B2—polycystic ovary syndrome	5.85e-06	0.000589	CbGpPWpGaD
Cefazolin—ALB—Metabolism—AKR1C1—polycystic ovary syndrome	5.67e-06	0.000571	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SULT2A1—polycystic ovary syndrome	5.22e-06	0.000525	CbGpPWpGaD
Cefazolin—ALB—Metabolism—RRM2—polycystic ovary syndrome	5.05e-06	0.000509	CbGpPWpGaD
Cefazolin—ALB—Metabolism—YAP1—polycystic ovary syndrome	4.87e-06	0.00049	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—IGF1—polycystic ovary syndrome	4.85e-06	0.000488	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—AKT2—polycystic ovary syndrome	4.84e-06	0.000488	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NAMPT—polycystic ovary syndrome	4.68e-06	0.000471	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	4.65e-06	0.000468	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP11A1—polycystic ovary syndrome	4.62e-06	0.000465	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—SERPINE1—polycystic ovary syndrome	4.6e-06	0.000463	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	4.59e-06	0.000462	CbGpPWpGaD
Cefazolin—ALB—Metabolism—AKR1C3—polycystic ovary syndrome	4.36e-06	0.000439	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP17A1—polycystic ovary syndrome	4.3e-06	0.000432	CbGpPWpGaD
Cefazolin—ALB—Metabolism—TH—polycystic ovary syndrome	3.72e-06	0.000374	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SLC2A4—polycystic ovary syndrome	3.62e-06	0.000364	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP19A1—polycystic ovary syndrome	3.4e-06	0.000342	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—VEGFA—polycystic ovary syndrome	3.17e-06	0.000319	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GNAS—polycystic ovary syndrome	3.03e-06	0.000305	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NCOR1—polycystic ovary syndrome	2.89e-06	0.000291	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP1A1—polycystic ovary syndrome	2.74e-06	0.000276	CbGpPWpGaD
Cefazolin—ALB—Metabolism—MTHFR—polycystic ovary syndrome	2.55e-06	0.000257	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PPARG—polycystic ovary syndrome	2.07e-06	0.000209	CbGpPWpGaD
Cefazolin—ALB—Metabolism—POMC—polycystic ovary syndrome	2.04e-06	0.000206	CbGpPWpGaD
Cefazolin—ALB—Metabolism—INS—polycystic ovary syndrome	2.03e-06	0.000205	CbGpPWpGaD
